Skip to Main content Skip to Navigation
Journal articles

Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary

Riemer H. J. A. Slart 1 Andor W. J. M. Glaudemans 1 Olivier Gheysens 2 Mark Lubberink 3 Tanja Kero 3 Marc R. Dweck 4 Gilbert Habib 5, 6 Oliver Gaemperli 7 Antti Saraste 8 Alessia Gimelli 9 Panagiotis Georgoulias 10 Hein J. Verberne 11 Jan Bucerius 12 Christoph Rischpler 13 Fabien Hyafil 14, 15 Paola A. Erba 16, 17 European Assoc Nucl Med Eanm
1 UMCG - University Medical Center Groningen [Groningen]
2 Cliniques Universitaires Saint-Luc [Bruxelles]
3 Uppsala University
4 University of Edinburgh
5 MEPHI - Microbes évolution phylogénie et infections
6 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
7 Hirslanden Medical Center
8 Department of Radiology, Turku PET Center
9 Fondazione Toscana Gabriele Monasterio
10 Univ Hosp Larissa
11 Department of Radiology and Nuclear Medicine [Amsterdam]
12 UMG - University Medical Center Göttingen
13 University of Duisburg-Essen
14 CIC - CHU Bichat
15 LVTS (UMR_S_1148 / U1148) - Laboratoire de Recherche Vasculaire Translationnelle
16 University of Pisa - Università di Pisa
17 Univ Groningen
Abstract : With this summarized document we share the standard for positron emission tomography (PET)/(diagnostic)computed tomography (CT) imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is) as recently published in the European Journal of Nuclear Medicine and Molecular Imaging. This standard should be applied in clinical practice and integrated in clinical (multicentre) trials for optimal standardization of the procedurals and interpretations. A major focus is put on procedures using [F-18]-2-fluoro-2-deoxyglucose ([F-18]FDG), but 4Is PET radiopharmaceuticals beyond [F-18]FDG are also described in this summarized document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicentre trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Diagnosis and management of 4Is related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/magnetic resonance, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.
Document type :
Journal articles
Complete list of metadata
https://hal-amu.archives-ouvertes.fr/hal-03149228
Contributor : Isabelle Combe <>
Submitted on : Monday, February 22, 2021 - 8:00:56 PM
Last modification on : Thursday, April 15, 2021 - 3:08:19 PM

Links full text

openaccess

Identifiers

Collections

UNIV-AMU | CNRS | UNIV-PARIS13 | UNIV-PARIS | SORBONNE-PARIS-NORD | UP-SANTE | INSERM | USPC

Citation

Riemer H. J. A. Slart, Andor W. J. M. Glaudemans, Olivier Gheysens, Mark Lubberink, Tanja Kero, et al.. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2020, 21 (12), pp.1320-1330. ⟨10.1093/ehjci/jeaa299⟩. ⟨hal-03149228⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

31